(Hypertension. 1999;33:248-255.)
© 1999 American Heart Association, Inc.
Scientific Contribution |
Telemetry for Cardiovascular Monitoring in a Pharmacological Study
New Approaches to Data Analysis
From the Department of Medicine and Therapeutics, University of Glasgow, Scotland, UK, and the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH (N.J.S.).
Correspondence to Dr N.H. Anderson, Department of Medicine and Therapeutics, Western Infirmary, Glasgow, G11 6NT, UK. E-mail niall{at}stats.gla.ac.uk
Abstract—Radio-telemetry systems offer the ability to measure blood pressure and heart rate in experimental models of hypertension without the stress artifacts induced by some other methods. We therefore aimed to develop improved, nonparametric regression methods for radio-telemetry data and to use these to assess the effects of pharmacological interventions on cardiac and vascular hypertrophy in the stroke-prone spontaneously hypertensive rat. One control group and 5 groups treated either with losartan (alone or in combination with NG-nitro-L-arginine methyl ester [ L-NAME]), perindopril (also alone or in combination with L-NAME), or hydralazine plus hydrochlorothiazide were monitored for 4 weeks. Cardiac hypertrophy was assessed by the left ventricle plus septum weight to body weight ratio and vascular hypertrophy by flow-cytometry analysis of vascular smooth muscle cell polyploidy. Hemodynamic series were split into trend and cyclic components by the seasonal and trend decomposition procedure based on Loess and compared between groups by Loess regression modeling. Systolic and diastolic blood pressures were reduced systematically by losartan and perindopril (P<10-10) but to a lesser extent by hydralazine plus hydrochlorothiazide (P<10-8), and diurnal variation was reduced in the latter group (P<10-6). L-NAME significantly reduced the hypotensive effect only of losartan. Vascular and cardiac hypertrophy were significantly attenuated with losartan or perindopril, but were unchanged with other treatments. The new analysis proposed here identifies differential effects on trends and cyclic variation and associations with regression of end-organ damage for losartan and perindopril compared with hydralazine plus hydrochlorothiazide. The method offers a powerful tool for detailed investigation of radio-telemetry data.
Key Words: telemetry • statistics • hypertension, genetic • hypertrophy, cardiac • rats
This article has been cited by other articles:
 |
|
 |
|
  D. O'Regan, C. J Kenyon, J. R Seckl, and M. C Holmes Prenatal dexamethasone 'programmes' hypotension, but stress-induced hypertension in adult offspring J. Endocrinol., February 1, 2008; 196(2): 343 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Douglas, J. A. Armitage, P. D. Taylor, J. R. Lawson, G. E. Mann, and L. Poston Cardiovascular consequences of life-long exposure to dietary isoflavones in the rat J. Physiol., March 1, 2006; 571(2): 477 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Kurtz, K. A. Griffin, A. K. Bidani, R. L. Davisson, and J. E. Hall Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 2: Blood Pressure Measurement in Experimental Animals. A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): e22 - e33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. Kurtz, K. A. Griffin, A. K. Bidani, R. L. Davisson, and J. E. Hall Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 2: Blood Pressure Measurement in Experimental Animals: A Statement for Professionals From the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research Hypertension, February 1, 2005; 45(2): 299 - 310. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kramer and L. B. Kinter Evaluation and applications of radiotelemetry in small laboratory animals Physiol Genomics, May 13, 2003; 13(3): 197 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Kurtz False Claims of Blood Pressure-Independent Protection by Blockade of the Renin Angiotensin Aldosterone System? Hypertension, February 1, 2003; 41(2): 193 - 196. [Full Text] [PDF]
|
|
|
|
|
|
C. Yagil, N. Hubner, R. Kreutz, D. Ganten, and Y. Yagil Congenic strains confirm the presence of salt-sensitivity QTLs on chromosome 1 in the Sabra rat model of hypertension Physiol Genomics, January 15, 2003; 12(2): 85 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Y. Khan, P. D. Taylor, V. Dekou, P. T. Seed, L. Lakasing, D. Graham, A. F. Dominiczak, M. A. Hanson, and L. Poston Gender-Linked Hypertension in Offspring of Lard-Fed Pregnant Rats Hypertension, January 1, 2003; 41(1): 168 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Alemayehu, L. Breen, and M. P. Printz A new inbred Wistar-Kyoto rat substrain exhibiting apparent salt sensitivity and borderline hypertension Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1181 - H1190. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kishi, Y. Hirooka, K. Sakai, H. Shigematsu, H. Shimokawa, and A. Takeshita Overexpression of eNOS in the RVLM Causes Hypotension and Bradycardia Via GABA Release Hypertension, October 1, 2001; 38(4): 896 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Negrin, M. W. McBride, H. V. O. Carswell, D. Graham, F. J. Carr, J. S. Clark, B. Jeffs, N. H. Anderson, I. M. Macrae, and A. F. Dominiczak Reciprocal Consomic Strains to Evaluate Y Chromosome Effects Hypertension, February 1, 2001; 37(2): 391 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Sakai, Y. Hirooka, I. Matsuo, K. Eshima, H. Shigematsu, H. Shimokawa, and A. Takeshita Overexpression of eNOS in NTS Causes Hypotension and Bradycardia In Vivo Hypertension, December 1, 2000; 36(6): 1023 - 1028. [Abstract] [Full Text] [PDF]
|
|